Anybody who watches television, surfs the Internet or
flips through a magazine is very familiar with advertising
for pharmaceutical drugs picturing attractive, healthy
and active people. Prescription and over the counter
drugs are used by millions of consumers for various
ailments, diseases and medical conditions. For most,
prescription drugs can provide great benefit or relief.
A consequence of the development of many drugs and the marketing
to millions of consumers, are serious side effects or other undesired
results. In extreme cases, the U.S. Food & Drug Administration (FDA) or manufacturer
may recall or withdraw a drug.
Over the past few years, the safety of more than a dozen popular prescription
drugs has been examined. In some cases, certain drugs have been recalled following reports of serious injury or death.
The recent recall of numerous popular drugs has resulted in heightened scrutiny of certain blockbuster drugs with hearings before Congress in which at least one FDA researcher suggests that the FDA may be incapable of protecting consumers from unsafe drugs and that several other popular drugs currently on the market may also present unacceptable patient risk. According to a survey by the Department of Health & Human Services Office of Inspector General, about two-thirds of Food & Drug Administration scientists are less than fully confident in the agency's monitoring of the safety of prescription drugs now being sold.
DrugRecalls.com is a consumer resource from product liability lawyers
engaged in assisting consumers suffering
side effects from pharmaceutical drugs.
Not all drugs referenced on this website have been subject to recall or warning. Patients should never stop taking their medicine without first consulting with their physician.
FILING DEADLINE
FOR AVANDIA CLAIMS: 
PAXIL LINKED TO BIRTH DEFECTS: Studies suggest use of Paxil and other types of antidepressants during pregnancy may cause serious birth defects including, brain and spinal cord injury, heart injury, lung injury, abnormally shaped head/skull, abdominal wall injury, and club foot, and closure of the anus. On
December 8, 2005 the U.S. Food and Drug Administration (FDA) issued a Public Health Advisory for Paxil, based on American and Swedish studies, showing that use of Paxil in the first trimester of pregnancy may increase the risk of heart defects.
The FDA issued a second advisory
on July 19, 2006, based on evidence showing their use may be linked to persistent pulmonary hypertension (PPHN), a life-threatening lung condition.
